Home › Trial NCT07775209
Shortening Radiation Course Duration Using Simultaneous Integrated Boost With Lower Intensity Elective Nodal Dosing and Concurrent Chemotherapy for High-Risk Anal Squamous Cell Carcinoma
- Trial IDNCT07775209
- StatusEnrolling By Invitation
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity of Vermont Medical Center
- Enrollment24
- Start date2026-08-26
- ConditionsAnal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.